H. E. Scholtz
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
-
- Pancreatic function and diabetes
Papers in
-
- Diabetes Management and Research 6
- Diabetes Treatment and Management 4
- Surgery 5
- Pancreatic function and diabetes 4
- Co-authors
- R. H. A. Becker (4 shared papers)D. H. Wessels (4 shared papers)Annke Frick (2 shared papers)Maria Potgieter (3 shared papers)F J Burger (1 shared paper)Claudio Perret (1 shared paper)Guy Montay (1 shared paper)B. Lenfant (1 shared paper)
- Journals
- Experimental and Clinical Endocrinology & Diabetes (2 papers)Current Medical Research and Opinion (1 paper)Diabetologia (1 paper)British Journal of Clinical Pharmacology (1 paper)Chemotherapy (1 paper)
- Partner nations
- South AfricaUnited StatesUnited Kingdom
In The Last Decade
H. E. Scholtz
10 papers receiving 394 citations
Peers
Comparison fields: 5 of 68
- Endocrinology, Diabetes and Metabolism 306
- Surgery 216
- Genetics 101
- Molecular Medicine 12
- Pharmacology 30
Countries citing papers authored by H. E. Scholtz
This map shows the geographic impact of H. E. Scholtz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. E. Scholtz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. E. Scholtz more than expected).
Fields of papers citing papers by H. E. Scholtz
This network shows the impact of papers produced by H. E. Scholtz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. E. Scholtz. The network helps show where H. E. Scholtz may publish in the future.
Co-authors
The 20 scholars most cited alongside H. E. Scholtz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 101 | |
| 2 | 2005 | 92 | |
| 3 | 2005 | 73 | |
| 4 | 2002 | 43 | |
| 5 | 2005 | 34 | |
| 6 | 1995 | 25 | |
| 7 | 2003 | 20 | |
| 8 | Humalog Mix25 improves 24-hour plasma glucose profiles compared with the human insulin mixture 30/70 in patients with type 2 diabetes mellitus. | 2003 | 17 |
| 9 | 1994 | 12 | |
| 10 | 1980 | 2 |
About H. E. Scholtz
H. E. Scholtz is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Analytical Chemistry, Infectious Diseases and Molecular Biology, having authored 10 papers that have together received 419 indexed citations. Recurring topics across this work include Diabetes Management and Research (6 papers), Pancreatic function and diabetes (4 papers), Diabetes Treatment and Management (4 papers), Cancer Treatment and Pharmacology (1 paper), Analytical Methods in Pharmaceuticals (1 paper), Pharmaceutical Practices and Patient Outcomes (1 paper), Metabolism, Diabetes, and Cancer (1 paper) and Health Systems, Economic Evaluations, Quality of Life (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (306 citations), Surgery (216 citations), Genetics (101 citations), Molecular Medicine (12 citations) and Pharmacology (30 citations). H. E. Scholtz has collaborated with scholars based in South Africa, United States and United Kingdom. Frequent co-authors include R. H. A. Becker, D. H. Wessels, Annke Frick, Maria Potgieter, F J Burger, Claudio Perret, Guy Montay, B. Lenfant, Robert Schall and Vipin Arora. Their work appears in journals such as Experimental and Clinical Endocrinology & Diabetes, Current Medical Research and Opinion, Diabetologia, British Journal of Clinical Pharmacology and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.